OWL Oncology Research Adopts Veeva to Elevate Clinical Trial Operations

Running a clinical trial requires precision, speed, and confidence in the systems that manage study data, documents, and compliance. For small and mid-sized biopharma and biotech sponsors, accessing that infrastructure has traditionally meant choosing between costly full-service CROs or juggling a patchwork of manual trackers.

At OWL Oncology Research, we’re changing that.

We have officially adopted Veeva CTMS and eTMF, industry-leading platforms for clinical trial management and document integrity. This gives sponsors access to world-class technology within our flexible, high-quality functional service provider (FSP) model.

This investment strengthens our ability to support sponsor companies across the spectrum, from established and growing biotechs to fast-moving venture capital backed start-ups, as well as the seasoned independent contractors who collaborate with us to deliver exceptional clinical services.

Why Veeva, and Why Now?

“We want to make the functional service provider model easier for sponsors,” says Joe Mudd, Co-Founder and Director of Business Development. “Veeva provides us with the industry’s best critical systems, without forcing sponsors to take on the huge cost and time of implementation or rely on a CROs home-grown system, which may be outdated and difficult to navigate.”

For early-stage and growing biotechs, implementing CTMS and eTMF tools independently is often unrealistic or impractical. Yet these systems are essential for running a clean, compliant, and audit-ready study. Our adoption of Veeva into our operational infrastructure gives sponsors immediate access to a validated, enterprise-grade platform that ensures high-quality clinical execution.

A Single Source of Truth for Every Trial

One of the most significant operational challenges in clinical research is the widespread reliance on manual trackers or spreadsheets stored on shared drives and missing version control. As studies grow, these tools introduce risk, inefficiency, and communication gaps.

“When studies get bigger, manual trackers break down,” Joe explains. “With Veeva, everyone works in the same system at the same time. It’s a much cleaner, more accurate way to run a trial.”

With Veeva CTMS, sponsors gain real-time visibility into:

• Monitoring visit schedules and trip reports

• Protocol deviations

• Site activation progress and enrollment metrics

• Study, Country and Site level milestones

• Document statuses and overdue items

• Site contact information

• EDC integration to automate data transfers between systems

• Advanced reporting dashboards for full clinical trial transparency

With Veeva, sponsors no longer waste time switching between systems or searching for the latest files. They see real-time study data in one place, driving faster, more informed decisions and giving leadership and Boards full visibility into study health.

Streamlined Compliance and Audit Readiness

The eTMF brings additional structure and control to study documentation. Beyond serving as a secure, validated repository, it guides the required sequencing of documents and milestones to ensure nothing is overlooked.

“With Veeva, we can give auditors exactly what they need without the clutter of manual trackers,” Joe says. “It keeps audits clean and efficient.”

We can limit both:

• How long auditors have access

• Limit access only to documents that are in their final and QCs status

This ensures appropriate visibility while protecting sensitive or unrelated study materials.

Better Tools for Contractors, Smoother Collaboration

Veeva also enhances the daily workflow of our experienced contractors and functional experts.

Features like collaborative authoring allow multiple contributors to work within the same document simultaneously, without overwriting each other’s edits. Electronic signatures ensure Part 11–compliant approvals, and centralized workflows greatly reduce administrative burden.

“It’s a one-stop shop,” notes Nicole Wong, who leads the Veeva implementation. “On previous studies, I’ve dealt with so many manual trackers. Having everything centralized makes life much easier for contractors.”

This efficiency ultimately supports smoother, faster study execution for sponsors.

More Competitive Than Ever — Without Becoming a CRO

Sponsors often compare FSPs and CROs when deciding how to structure their studies. CROs have historically held an advantage because they own the necessary operational systems. With Veeva in place, we now match that capability while retaining the flexibility and quality that set OWL apart.

“Improving our infrastructure positions us to win more projects,” Joe says. “We can now offer higher quality systems with better quality resourcing and more affordable pricing.”

With Veeva, and in collaboration with our vendor partners, Sponsors now gain the full-service CRO experience — without having to work with a full-service CRO.

A Platform That Will Grow with Us and the Sponsors We Serve

Veeva continues to expand its capabilities, including AI-powered tools that will automate routine tasks such as identifying expired documents or surfacing key insights before a monitoring visit.

“Veeva is the industry leader,” Joe notes. “They’re not going away, and they’re ahead of the curve - especially with new AI tools that will make work even easier for our monitors.”

With Veeva, we’ve built a future-ready foundation that allows us to scale alongside sponsors as their programs advance.

The Bottom Line

As Joe summarizes:

“Our sponsors are one step closer to a full-service CRO experience without the hefty price tag associated with the traditional CRO.”

By adopting Veeva CTMS and eTMF, we’re strengthening the quality, transparency, and operational excellence sponsors expect from OWL and setting a higher standard for what an FSP partner can deliver.